Quantifying Clinical Utility of Enzalutamide for Overall Survival in Metastatic Hormone-Sensitive Prostate Cancer. Sun R, Wei LJ. J Clin Oncol 2022 Aug 19:JCO2201084. doi: 10.1200/JCO.22.01084.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sun R, Wei LJ. Quantifying Clinical Utility of Enzalutamide for Overall Survival in Metastatic Hormone-Sensitive Prostate Cancer. J Clin Oncol 2022 Aug 19:JCO2201084. doi: 10.1200/JCO.22.01084.
PMID: 35985008